Discovery of novel and orally active inhibitors of lck kinase.

被引:0
|
作者
Goldberg, D [1 ]
Butz, T [1 ]
Cardozo, M [1 ]
Eckner, R [1 ]
Hammach, A [1 ]
Huang, J [1 ]
Jakes, S [1 ]
Kapadia, S [1 ]
Lukas, S [1 ]
Morwick, T [1 ]
Moss, N [1 ]
Panzenbeck, M [1 ]
Patel, U [1 ]
Peet, G [1 ]
Peterson, J [1 ]
Prokopowicz, A [1 ]
Snow, RJ [1 ]
Takahashi, H [1 ]
Tan, J [1 ]
Tschantz, M [1 ]
Wang, XJ [1 ]
Xiang, P [1 ]
Zinter, R [1 ]
机构
[1] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
24-MEDI
引用
收藏
页码:U643 / U643
页数:1
相关论文
共 50 条
  • [1] Discovery and progression of a novel series of orally active p38 kinase inhibitors.
    Leftheris, K
    Ahmed, G
    Chan, R
    Dyckman, A
    Hynes, J
    Lin, SQ
    Metzger, A
    Moriarty, K
    Shimshock, Y
    Wen, J
    Wityak, J
    Wrobleski, S
    Wu, H
    Wu, JJ
    Behnia, K
    Doweyko, AM
    Gillooly, K
    Lin, T
    Loo, D
    McIntyre, K
    Pitt, S
    Shen, DR
    Shuster, D
    Zhang, HJ
    Zhang, R
    Barrish, J
    Dodd, J
    Henderson, I
    Schieven, G
    Webb, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U939 - U939
  • [2] MEDI 475-Discovery of orally active met kinase inhibitors
    Cai, Zhen-wei
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
  • [3] Discovery of bardoxolone derivatives as novel orally active necroptosis inhibitors
    Wang, Yuanyuan
    Ma, Hao
    Huang, Jiaxuan
    Yao, Zhengguang
    Yu, Jianqiang
    Zhang, Wannian
    Zhang, Lichao
    Wang, Zhibin
    Zhuang, Chunlin
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 212
  • [4] Discovery and design of novel benzimidazolone as inhibitors of p38 MAP kinase.
    Hammach, A
    Ralph, M
    Corbo, F
    Barbosa, A
    Liu, PR
    Soleymanzadeh, F
    Goldberg, D
    Sarko, C
    Mckibben, B
    Moss, N
    Hao, MH
    White, A
    Qian, K
    Pargellis, C
    Kroe, R
    Wildeson, J
    Nelson, R
    Fadra, T
    Capolino, A
    Kashem, M
    Patnaude, L
    Madwed, J
    Torcellini, C
    Kaplita, P
    Farrel, T
    Hu, HB
    Yazdania, M
    Kavanaugh, K
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U947 - U947
  • [5] Discovery of novel 2-(aminoheteroaryl)-thiazole-5-carboxamides as potent and orally active Src-family kinase p56Lck inhibitors
    Ping, C
    Norris, D
    Das, J
    Spergel, SH
    Wityak, J
    Leith, L
    Zhao, RL
    Chen, BC
    Pitt, S
    Pang, SH
    Ding, RS
    Zhang, R
    De Fex, HF
    Doweyko, AM
    McIntyre, KW
    Shuster, DJ
    Behnia, K
    Schieven, GL
    Barrish, JC
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (24) : 6061 - 6066
  • [6] Novel substituted 4-anilinoquinoline-3-carbonitriles as orally active, irreversible binding inhibitors of Her-2 kinase.
    Tsou, HR
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U3 - U3
  • [7] Discovery of Orally Active JNK Inhibitors
    Satoh, Yoshitaka
    INFLAMMATION RESEARCH, 2005, 54 : S134 - S135
  • [8] 2-Phenylamino-imidazo[4,5-H]isoquinolin-9-ones novel and highly active inhibitors of LCK kinase.
    Hammach, A
    Butz, T
    Cardozo, M
    Eckner, R
    Goldberg, D
    Huang, J
    Jakes, S
    Kapadia, S
    Kirrane, T
    Kuzmich, D
    Lukas, S
    Morwick, T
    Moss, N
    Mulrooney, C
    Panzenbeck, M
    Patel, U
    Peet, G
    Peterson, J
    Prokopowicz, A
    Proudfoot, J
    Snow, RJ
    Takahashi, H
    Tan, J
    Tschantz, M
    Wang, XJ
    Xiong, P
    Zinter, R
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 222 : U685 - U685
  • [9] Discovery of potent and selective orally active inhibitors of anaplastic lymphoma kinase (ALK)
    Shakespeare, William
    Fantin, Valeria
    Wang, Frank
    Kohlmann, Anna
    Liu, Shuangying
    Huang, Wei-Sheng
    Wang, Yihan
    Zou, Dong
    Thomas, Mathew
    Li, Feng
    Qi, Jiwei
    Cai, Lisi
    Dwight, Thimothy
    Xu, Yongjin
    Xu, Rongsong
    Dodd, Rory
    Xu, Qihong
    Anjum, Rana
    Zhang, Sen
    Keats, Jeffrey
    Xue, Ling
    Wardwell, Scott
    Ning, Yaoyu
    Moran, Lauren
    Mohemmad, Qurish
    Zhu, Xiaotian
    Narasimhan, Narayana
    Rivera, Victor
    Dalgarno, David
    Clackson, Tim
    CANCER RESEARCH, 2009, 69
  • [10] Discovery of orally bioavailable Aurora kinase inhibitors
    Zhang, Yonglian
    Yu, Tao
    Tagat, Jayaram R.
    Xiao, Yushi
    Kerekes, Angela D.
    Doll, Ronald J.
    Esposite, Sara
    Hruza, Alan
    Voss, Matthew
    Rainka, Matthew
    Basso, Andrea D.
    Gray, Kimberly
    Tevar, Seema
    Kirschmeier, Paul
    Liu, Ming
    Liang, Lianzhu
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241